P784: A PHASE I/II STUDY OF VENETOCLAX IN COMBINATION WITH ASTX727 (DECITABINE/CEDAZURIDINE) IN TREATMENT‐NAÏVE HIGH‐RISK MYELODYSPLASTIC SYNDROME (MDS) OR CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML)

• S. Venugopal,
• H. kantarjian,
• A. Maiti,
• N. Short,
• G. Montalban-Bravo,
• Y. Alvarado,
• K. S. Chien,
• R. Kanagal-Shamanna,
• N. Pemmaraju,
• N. Daver,
• T. Kadia,
• G. Borthakur,
• E. Jabbour,
• G. Garcia-Manero

Affiliations

S. Venugopal

1 Leukemia

H. kantarjian

1 Leukemia

A. Maiti

1 Leukemia

N. Short

1 Leukemia

G. Montalban-Bravo

1 Leukemia

Y. Alvarado

1 Leukemia

K. S. Chien

1 Leukemia

R. Kanagal-Shamanna

2 Hematopathology, The University of Texas, MD Anderson Cancer Center, Houston, United States of America

N. Pemmaraju

1 Leukemia

N. Daver

1 Leukemia

T. Kadia

1 Leukemia

G. Borthakur

1 Leukemia

E. Jabbour

1 Leukemia

G. Garcia-Manero

1 Leukemia